Teleflex named Sean M. Salmon to its board, effective Sept. 8, 2026.
Salmon spent more than 20 years at Medtronic, most recently as EVP and president of its Cardiovascular Portfolio with fiscal 2025 revenue of about $12.5 billion.
He also serves as an independent director at Adagio Medical Holdings.
Salmon will join Teleflex’s Growth and Operating Committee, created earlier this year to support the company’s strategic transformation.
TFX•
